Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, Krolewski AS, Bonventre JV.

Kidney Int. 2011 Feb;79(4):464-70. doi: 10.1038/ki.2010.404. Epub 2010 Oct 27.

2.

Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.

Fu WJ, Xiong SL, Fang YG, Wen S, Chen ML, Deng RT, Zheng L, Wang SB, Pen LF, Wang Q.

Endocrine. 2012 Feb;41(1):82-8. doi: 10.1007/s12020-011-9509-7. Epub 2011 Jul 21.

PMID:
21779943
3.

Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.

Kim SS, Song SH, Kim IJ, Yang JY, Lee JG, Kwak IS, Kim YK.

Diabetes Res Clin Pract. 2012 Aug;97(2):251-7. doi: 10.1016/j.diabres.2012.02.019. Epub 2012 Mar 21.

PMID:
22440044
4.

Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.

Fujita H, Morii T, Koshimura J, Ishikawa M, Kato M, Miura T, Sasaki H, Narita T, Ito S, Kakei M.

Endocr J. 2006 Dec;53(6):745-52. Epub 2006 Sep 12.

5.

Glomerular and tubular damage markers are elevated in patients with diabetes.

Nauta FL, Boertien WE, Bakker SJ, van Goor H, van Oeveren W, de Jong PE, Bilo H, Gansevoort RT.

Diabetes Care. 2011 Apr;34(4):975-81. doi: 10.2337/dc10-1545. Epub 2011 Feb 9.

6.

Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.

Bouvet BR, Paparella CV, Arriaga SM, Monje AL, Amarilla AM, Almará AM.

Arq Bras Endocrinol Metabol. 2014 Nov;58(8):798-801. Epub 2014 Nov 1.

7.

Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.

Fu WJ, Li BL, Wang SB, Chen ML, Deng RT, Ye CQ, Liu L, Fang AJ, Xiong SL, Wen S, Tang HH, Chen ZX, Huang ZH, Peng LF, Zheng L, Wang Q.

Diabetes Res Clin Pract. 2012 Jan;95(1):105-9. doi: 10.1016/j.diabres.2011.09.031. Epub 2011 Oct 20.

PMID:
22015481
8.
9.

Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.

Piwowar A, Knapik-Kordecka M, Fus I, Warwas M.

Med Sci Monit. 2006 May;12(5):CR210-4.

PMID:
16641878
10.

Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.

Waanders F, Vaidya VS, van Goor H, Leuvenink H, Damman K, Hamming I, Bonventre JV, Vogt L, Navis G.

Am J Kidney Dis. 2009 Jan;53(1):16-25. doi: 10.1053/j.ajkd.2008.07.021. Epub 2008 Sep 27.

11.

Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors.

Conway BR, Manoharan D, Manoharan D, Jenks S, Dear JW, McLachlan S, Strachan MW, Price JF.

Kidney Int. 2012 Oct;82(7):812-8. doi: 10.1038/ki.2012.218. Epub 2012 Jun 20.

12.

Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?

Patrick AW, Oliver MD, Howie AF, Dawes J, Macintyre CC, Frier BM.

Diabete Metab. 1990 Sep-Oct;16(5):441-7.

PMID:
2150050
13.

Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT).

Kern EF, Erhard P, Sun W, Genuth S, Weiss MF.

Am J Kidney Dis. 2010 May;55(5):824-34. doi: 10.1053/j.ajkd.2009.11.009.

14.

Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.

Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S.

J Diabetes Complications. 2003 Jan-Feb;17(1):11-5.

PMID:
12505750
15.

Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.

von Eynatten M, Baumann M, Heemann U, Zdunek D, Hess G, Nawroth PP, Bierhaus A, Humpert PM.

Eur J Clin Invest. 2010 Feb;40(2):95-102. doi: 10.1111/j.1365-2362.2009.02220.x. Epub 2009 Nov 11.

PMID:
19912308
16.

Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.

Kim SS, Song SH, Kim IJ, Kim WJ, Jeon YK, Kim BH, Kwak IS, Lee EK, Kim YK.

Diabetes Metab Res Rev. 2014 Nov;30(8):736-41. doi: 10.1002/dmrr.2546.

PMID:
24687388
17.

Serum and urinary cytokine homeostasis and renal tubular function in children with type 1 diabetes mellitus.

Myśliwiec M, Balcerska A, Zorena K, Myśliwska J, Lipska BS, Wiśniewski P, Myśliwski A.

J Pediatr Endocrinol Metab. 2006 Dec;19(12):1421-7.

PMID:
17252695
18.

Renal tubular proteinuria and microalbuminuria in diabetic patients.

Gibb DM, Tomlinson PA, Dalton NR, Turner C, Shah V, Barratt TM.

Arch Dis Child. 1989 Jan;64(1):129-34.

19.

Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes.

Kim SR, Lee YH, Lee SG, Kang ES, Cha BS, Kim JH, Lee BW.

Medicine (Baltimore). 2016 Jul;95(27):e4114. doi: 10.1097/MD.0000000000004114.

20.

Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.

Nielsen SE, Andersen S, Zdunek D, Hess G, Parving HH, Rossing P.

Kidney Int. 2011 May;79(10):1113-8. doi: 10.1038/ki.2010.554. Epub 2011 Jan 26.

Supplemental Content

Support Center